Skip to main content
. 2014 Oct 13;9(10):e109756. doi: 10.1371/journal.pone.0109756

Figure 6. Inhibition of bortezomib and TRAIL induced DR4 internalization by z-VAD-FMK.

Figure 6

DR4 receptor cell surface expression and viability of the HCT116 p53+/+ cells were analyzed after incubation with 10 µM z-VAD-FMK for 1 h following treatments with TRAIL (1 ng/ml) and bortezomib (1 nM) or in combination of the two drugs.